0003-3120-01 : NDC 2026 Code

0003-3120-01 : Nivolumab And Hyaluronidase-nvhy ( Opdivo Qvantig )

Additionally :

You can get information about “0003-3120-01” NDC code in 0003-3120-01 in HTML format

HTML | 0003-3120-01 in TXT (Plain Text) format

TXT | 0003-3120-01 in PDF (Portable Document Format)

PDF | 0003-3120-01 in XML format

XML formats.

NDC Code : 0003-3120-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "0003-3120-01",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (0003-3120-01)  / 2.5 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "00003-3120-01",
    "ProductNDC": "0003-3120",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Opdivo Qvantig",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Nivolumab And Hyaluronidase-nvhy",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20241227",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761381",
    "LabelerName": "E.R. Squibb &amp; Sons, L.L.C.",
    "SubstanceName": "HYALURONIDASE (HUMAN RECOMBINANT); NIVOLUMAB",
    "StrengthNumber": "2000; 120",
    "StrengthUnit": "U/mL; mg/mL",
    "Pharm_Classes": "Endoglycosidase [EPC], Glycoside Hydrolases [CS], Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-16",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20251124",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}